188 related articles for article (PubMed ID: 34577013)
1. Targeted Downregulation of MYC through G-quadruplex Stabilization by DNAi.
Psaras AM; Chang KT; Hao T; Brooks TA
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577013
[TBL] [Abstract][Full Text] [Related]
2. Piperine analogs arrest c-myc gene leading to downregulation of transcription for targeting cancer.
Pandya N; Kumar A
Sci Rep; 2021 Nov; 11(1):22909. PubMed ID: 34824301
[TBL] [Abstract][Full Text] [Related]
3. Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression.
Felsenstein KM; Saunders LB; Simmons JK; Leon E; Calabrese DR; Zhang S; Michalowski A; Gareiss P; Mock BA; Schneekloth JS
ACS Chem Biol; 2016 Jan; 11(1):139-48. PubMed ID: 26462961
[TBL] [Abstract][Full Text] [Related]
4. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
[TBL] [Abstract][Full Text] [Related]
5. Nucleic acid clamp-mediated recognition and stabilization of the physiologically relevant MYC promoter G-quadruplex.
Hao T; Gaerig VC; Brooks TA
Nucleic Acids Res; 2016 Dec; 44(22):11013-11023. PubMed ID: 27789698
[TBL] [Abstract][Full Text] [Related]
6. Targeting MYC Regulation with Polypurine Reverse Hoogsteen Oligonucleotides.
Valiuska S; Psaras AM; Noé V; Brooks TA; Ciudad CJ
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613820
[TBL] [Abstract][Full Text] [Related]
7. Human MYC G-quadruplex: From discovery to a cancer therapeutic target.
Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579
[TBL] [Abstract][Full Text] [Related]
8. G-quadruplex DNA structure is a positive regulator of
Esain-Garcia I; Kirchner A; Melidis L; Tavares RCA; Dhir S; Simeone A; Yu Z; Madden SK; Hermann R; Tannahill D; Balasubramanian S
Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2320240121. PubMed ID: 38315865
[TBL] [Abstract][Full Text] [Related]
9. Identification of G-Quadruplex-Binding Inhibitors of Myc Expression through Affinity Selection-Mass Spectrometry.
Flusberg DA; Rizvi NF; Kutilek V; Andrews C; Saradjian P; Chamberlin C; Curran P; Swalm B; Kattar S; Smith GF; Dandliker P; Nickbarg EB; O'Neil J
SLAS Discov; 2019 Feb; 24(2):142-157. PubMed ID: 30204533
[TBL] [Abstract][Full Text] [Related]
10. Anticancer activity and cellular repression of c-MYC by the G-quadruplex-stabilizing 11-piperazinylquindoline is not dependent on direct targeting of the G-quadruplex in the c-MYC promoter.
Boddupally PV; Hahn S; Beman C; De B; Brooks TA; Gokhale V; Hurley LH
J Med Chem; 2012 Jul; 55(13):6076-86. PubMed ID: 22691117
[TBL] [Abstract][Full Text] [Related]
11. Indenoisoquinoline Topoisomerase Inhibitors Strongly Bind and Stabilize the
Wang KB; Elsayed MSA; Wu G; Deng N; Cushman M; Yang D
J Am Chem Soc; 2019 Jul; 141(28):11059-11070. PubMed ID: 31283877
[No Abstract] [Full Text] [Related]
12. Discovery of a fluorescent, long chain-bridged bispurine that selectively targets the c-MYC G-quadruplex.
Hu MH; Lin JH; Huang Q
Bioorg Chem; 2022 May; 122():105750. PubMed ID: 35325695
[TBL] [Abstract][Full Text] [Related]
13. A dihydroindolizino indole derivative selectively stabilizes G-quadruplex DNA and down-regulates c-MYC expression in human cancer cells.
Nagesh N; Raju G; Srinivas R; Ramesh P; Reddy MD; Reddy ChR
Biochim Biophys Acta; 2015 Jan; 1850(1):129-40. PubMed ID: 25452213
[TBL] [Abstract][Full Text] [Related]
14. Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex.
Dutta D; Debnath M; Müller D; Paul R; Das T; Bessi I; Schwalbe H; Dash J
Nucleic Acids Res; 2018 Jun; 46(11):5355-5365. PubMed ID: 29762718
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of G-quadruplex DNA with platinum(II) Schiff base complexes: luminescent probe and down-regulation of c-myc oncogene expression.
Wu P; Ma DL; Leung CH; Yan SC; Zhu N; Abagyan R; Che CM
Chemistry; 2009 Dec; 15(47):13008-21. PubMed ID: 19876976
[TBL] [Abstract][Full Text] [Related]
16. Benzothiazole hydrazones of furylbenzamides preferentially stabilize c-MYC and c-KIT1 promoter G-quadruplex DNAs.
Pany SP; Bommisetti P; Diveshkumar KV; Pradeepkumar PI
Org Biomol Chem; 2016 Jun; 14(24):5779-93. PubMed ID: 27021281
[TBL] [Abstract][Full Text] [Related]
17. New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription.
Hu MH; Wu TY; Huang Q; Jin G
Nucleic Acids Res; 2019 Nov; 47(20):10529-10542. PubMed ID: 31584090
[TBL] [Abstract][Full Text] [Related]
18. Specific Stabilization of c-MYC and c-KIT G-Quadruplex DNA Structures by Indolylmethyleneindanone Scaffolds.
Diveshkumar KV; Sakrikar S; Rosu F; Harikrishna S; Gabelica V; Pradeepkumar PI
Biochemistry; 2016 Jun; 55(25):3571-85. PubMed ID: 27226253
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a New Four-Leaf Clover-Like Ligand as a Potent c-MYC Transcription Inhibitor Specifically Targeting the Promoter G-Quadruplex.
Hu MH; Wang YQ; Yu ZY; Hu LN; Ou TM; Chen SB; Huang ZS; Tan JH
J Med Chem; 2018 Mar; 61(6):2447-2459. PubMed ID: 29474069
[TBL] [Abstract][Full Text] [Related]
20. Demonstration that drug-targeted down-regulation of MYC in non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex.
Brown RV; Danford FL; Gokhale V; Hurley LH; Brooks TA
J Biol Chem; 2011 Nov; 286(47):41018-27. PubMed ID: 21956115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]